Bicycle Therapeutics plc Files 8-K Report
Ticker: BCYC · Form: 8-K · Filed: Oct 31, 2024 · CIK: 1761612
Sentiment: neutral
Topics: financial-results, 8-k, reporting
Related Tickers: BCYC
TL;DR
BCYC filed an 8-K on 10/31/24 with financial results and exhibits.
AI Summary
On October 31, 2024, Bicycle Therapeutics plc filed an 8-K report detailing its financial results and operations. The filing includes financial statements and exhibits, providing an update on the company's performance. Specific financial figures and operational details are available within the comprehensive report.
Why It Matters
This filing provides investors with crucial, up-to-date information on Bicycle Therapeutics' financial health and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial results and does not indicate any unusual or significant risks.
Key Players & Entities
- Bicycle Therapeutics plc (company) — Registrant
- 0001104659-24-112848 (filing_id) — Accession Number
- October 31, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits for Bicycle Therapeutics plc.
When was this 8-K report filed?
This 8-K report was filed on October 31, 2024.
What is the company's full legal name and jurisdiction of incorporation?
The company's full legal name is Bicycle Therapeutics plc, and it is incorporated in England and Wales.
What is the Central Index Key (CIK) for Bicycle Therapeutics plc?
The Central Index Key (CIK) for Bicycle Therapeutics plc is 0001761612.
What is the Standard Industrial Classification (SIC) code for Bicycle Therapeutics plc?
The Standard Industrial Classification (SIC) code for Bicycle Therapeutics plc is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 559 words · 2 min read · ~2 pages · Grade level 12.8 · Accepted 2024-10-31 07:05:37
Filing Documents
- tm2426652d1_8k.htm (8-K) — 30KB
- tm2426652d1_ex99-1.htm (EX-99.1) — 64KB
- tm2426652d1_ex99-1img001.jpg (GRAPHIC) — 3KB
- 0001104659-24-112848.txt ( ) — 328KB
- bcyc-20241031.xsd (EX-101.SCH) — 3KB
- bcyc-20241031_def.xml (EX-101.DEF) — 26KB
- bcyc-20241031_lab.xml (EX-101.LAB) — 36KB
- bcyc-20241031_pre.xml (EX-101.PRE) — 25KB
- tm2426652d1_8k_htm.xml (XML) — 6KB
02
Item 2.02. Results of Operations and Financial Condition On October 31, 2024, Bicycle Therapeutics plc issued a press release announcing financial results for the fiscal quarter ended September 30, 2024 and other business highlights. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information contained in Item 2.02 in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 99.1 Press Release issued October 31, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 31, 2024 BICYCLE THERAPEUTICS PLC By: /s/ Alethia Young Name: Alethia Young Title: Chief Financial Officer